BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22342827)

  • 1. Designing multilayered particulate systems for tunable drug release profiles.
    Lee WL; Yu PO; Hong M; Widjaja E; Loo SC
    Acta Biomater; 2012 Jul; 8(6):2271-8. PubMed ID: 22342827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering the drug release profiles of double-layered ternary-phase microparticles.
    Lee WL; Loei C; Widjaja E; Loo SC
    J Control Release; 2011 May; 151(3):229-38. PubMed ID: 21352877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling of drug release from biodegradable triple-layered microparticles.
    Lee WL; Shi WX; Low ZY; Li S; Loo SC
    J Biomed Mater Res A; 2012 Dec; 100(12):3353-62. PubMed ID: 22733705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication and drug release study of double-layered microparticles of various sizes.
    Lee WL; Seh YC; Widjaja E; Chong HC; Tan NS; Loo SC
    J Pharm Sci; 2012 Aug; 101(8):2787-97. PubMed ID: 22573569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
    Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
    Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and degradation of biodegradable triple-layered microparticles.
    Lee WL; Hong M; Widjaja E; Loo SC
    Macromol Rapid Commun; 2010 Jul; 31(13):1193-200. PubMed ID: 21590875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of 3-D tumor spheroids by timed-released hydrophilic and hydrophobic drugs from multilayered polymeric microparticles.
    Lee WL; Guo WM; Ho VH; Saha A; Chong HC; Tan NS; Widjaja E; Tan EY; Loo SC
    Small; 2014 Oct; 10(19):3986-96. PubMed ID: 24947558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system.
    Lee WL; Widjaja E; Loo SC
    Small; 2010 May; 6(9):1003-11. PubMed ID: 20358528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(D,L-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour.
    Unger F; Wittmar M; Morell F; Kissel T
    Biomaterials; 2008 May; 29(13):2007-14. PubMed ID: 18262641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule release from poly(D,L-lactide)/poly(D,L-lactide-co-glycolide) composite microparticles.
    Pollauf EJ; Kim KK; Pack DW
    J Pharm Sci; 2005 Sep; 94(9):2013-22. PubMed ID: 16052542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonging food shelf-life by dual actives release from multi-layered polymer particles.
    Biswal AK; Saha S
    Colloids Surf B Biointerfaces; 2019 Mar; 175():281-290. PubMed ID: 30551015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of process parameters to achieve different ternary phase microparticle configurations.
    Lee WL; Foo WL; Widjaja E; Loo SC
    Acta Biomater; 2010 Apr; 6(4):1342-52. PubMed ID: 19854303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release from irradiated PLGA and PLLA multi-layered films.
    Loo SC; Tan ZY; Chow YJ; Lin SL
    J Pharm Sci; 2010 Jul; 99(7):3060-71. PubMed ID: 20112427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon.
    Krishnamachari Y; Madan P; Lin S
    Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
    Klose D; Delplace C; Siepmann J
    Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of PLLA/PLGA microparticles using solution enhanced dispersion by supercritical fluids (SEDS).
    Kang Y; Yin G; Ouyang P; Huang Z; Yao Y; Liao X; Chen A; Pu X
    J Colloid Interface Sci; 2008 Jun; 322(1):87-94. PubMed ID: 18402971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
    Zhao A; Rodgers VG
    J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step fabrication of core-shell structured alginate-PLGA/PLLA microparticles as a novel drug delivery system for water soluble drugs.
    Lim MPA; Lee WL; Widjaja E; Loo SCJ
    Biomater Sci; 2013 May; 1(5):486-493. PubMed ID: 32482012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.